These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 3271294)

  • 21. Pitfalls of glycated hemoglobin in the glycemic assessment of diabetes patients with hemoglobin louisville: role of serum fructosamine.
    Lorenzo-Medina M; de la Iglesia S; Ruiz-García L; Quintana-Hidalgo L; Martín-Alfaro R; Herrada J
    J Diabetes Sci Technol; 2013 May; 7(3):804-5. PubMed ID: 23759417
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum fructosamine as a screening test for type 2 diabetes.
    Klonoff DC
    Diabetes Technol Ther; 2000; 2(4):537-9. PubMed ID: 11469616
    [No Abstract]   [Full Text] [Related]  

  • 23. Glycated serum proteins and glucose tolerance.
    Lapolla A; Poli T; Meneghini F; Zucchetto M; Franchin A; Barison A; Fedele D
    Acta Diabetol Lat; 1988; 25(4):325-32. PubMed ID: 3245392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early and intensive treatment: Glycaemic control in type 2 diabetes.
    Bailey CJ
    Diab Vasc Dis Res; 2006 Dec; 3(3):145-6. PubMed ID: 17160908
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparative study of the glycosylated plasma proteins in diabetic Nigerians.
    Awojobi AO; Okotore RO; Ohwovoriole AE; Johnson TO
    West Afr J Med; 1991; 10(1):343-8. PubMed ID: 2069880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control.
    Wörner W; Pfleiderer S; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):218-22. PubMed ID: 8314651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Compliance to treatment and type 2 diabetes: impact on glycemic balance].
    Guillausseau PJ
    Presse Med; 2003 Jan; 32(2):70. PubMed ID: 12653029
    [No Abstract]   [Full Text] [Related]  

  • 28. Diabetes. Paradoxical effects of tightly controlled blood sugar.
    Taubes G
    Science; 2008 Oct; 322(5900):365-7. PubMed ID: 18927369
    [No Abstract]   [Full Text] [Related]  

  • 29. Glycosylated serum protein as an index of short term glycaemic control in non-insulin dependent diabetes mellitus.
    Harinarayana CV; Rathi AN; Sundaram A; Hariharan RS; Ganesan VS; Venkataraman S; Seshiah V
    Indian J Med Res; 1987 Nov; 86():641-5. PubMed ID: 3451909
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination therapy with multiple oral hypoglycaemic agents together with short-term basal insulin in new-onset Type 2 diabetes mellitus with marked hyperglycaemia.
    Ray S; Mukherjee JJ
    Diabet Med; 2017 Sep; 34(9):1322-1323. PubMed ID: 28586518
    [No Abstract]   [Full Text] [Related]  

  • 31. Postprandial hyperglycaemia--its importance and implications.
    Lüddeke HJ
    Int J Clin Pract Suppl; 1999 Jul; 104():3-7; discussion 18-20. PubMed ID: 12669731
    [No Abstract]   [Full Text] [Related]  

  • 32. [Intensive blood glucose reduction: yes or no?].
    Bischoff A
    MMW Fortschr Med; 2015 Mar; 157(4):18-9. PubMed ID: 25743962
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical significance of glycated erythrocyte membrane protein in the diagnosis of diabetes mellitus].
    Nakagawa S; Nakayama H
    Nihon Rinsho; 1990 Dec; 48 Suppl():432-8. PubMed ID: 2086918
    [No Abstract]   [Full Text] [Related]  

  • 34. [Type 2 diabetes -- higher doses of metformin improve metabolic control].
    Rosak C; Hövelmann R; Martin J
    MMW Fortschr Med; 2003 May; 145(21):39. PubMed ID: 12845866
    [No Abstract]   [Full Text] [Related]  

  • 35. Glycosylated proteins as an indicator of metabolic control in diabetes: evaluation by aminophenylboronic acid affinity chromatography.
    Ceriello A; dello Russo P; Curcio F; Paolisso G; Illiano G; Sgambato S; Giugliano D
    Acta Diabetol Lat; 1984; 21(1):49-54. PubMed ID: 6730847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of fructosamine with glycosylated hemoglobin and plasma proteins as measures of glycemic control.
    Smart LM; Howie AF; Young RJ; Walker SW; Clarke BF; Smith AF
    Diabetes Care; 1988 May; 11(5):433-6. PubMed ID: 3391095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Glycosylated proteins and control of the diabetic: use of continuous flow insulin pumps by the subcutaneous route].
    Maudelonde T; Menez JF; Meskar A; Tater D; Lucas D; Barbou LG; Bercovici JP
    Diabete Metab; 1983 Sep; 9(3):193-8. PubMed ID: 6653857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus.
    Fonseca V
    Curr Med Res Opin; 2003; 19(7):635-41. PubMed ID: 14606987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycaemic control in diabetes.
    Herman W
    Clin Evid; 2002 Jun; (7):529-37. PubMed ID: 12230678
    [No Abstract]   [Full Text] [Related]  

  • 40. Glycosylated serum protein levels assayed with highly sensitive immunoradiometric assay accurately reflect glycemic control of diabetic patients.
    Gordon A; Glaser B; Wald M; Del Rio G; Della Casa L; Gross J; Cerasi E
    Diabetes Care; 1992 May; 15(5):645-50. PubMed ID: 1516484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.